about
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney CancerThe evolution of genome-scale models of cancer metabolismPI3K/AKT/mTOR Pathway in AngiogenesisAlpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenationLactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cellsHypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.Oxidation in rheumatoid arthritis.Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activityProlyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibitionDeubiquitylating enzymes and diseaseThe FTO (fat mass and obesity associated) gene codes for a novel member of the non-heme dioxygenase superfamilyThe role of immunoglobulin superfamily cell adhesion molecules in cancer metastasisPI3K/PTEN/AKT signaling regulates prostate tumor angiogenesisA yeast two-hybrid system reconstituting substrate recognition of the von Hippel-Lindau tumor suppressor proteinThe peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stabilityPML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTORIOP1, a novel hydrogenase-like protein that modulates hypoxia-inducible factor-1alpha activityA role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasionHIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activityGene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control.Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repressionMetastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1.Identification and characterization of the human ARD1-NATH protein acetyltransferase complexHistone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alphaEAF2 suppresses hypoxia-induced factor 1α transcriptional activity by disrupting its interaction with coactivator CBP/p300Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesisTranscriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylationSiah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumorsThe candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasisVHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha.Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1Wnt/beta-catenin signaling and small molecule inhibitorsModes of resistance to anti-angiogenic therapyExpression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumorsHypoxia-induced methylation of a pontin chromatin remodeling factorDual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma'Desperate house genes': the dramatic example of hypoxia
P2860
Q21090542-33AA8FB4-922F-4DDB-A296-CA77C681974DQ21129241-0AF82013-F5F2-43CE-92CB-026D50B2B264Q21129332-FD616C23-571C-4F6B-AEB9-6011A851B882Q21133512-F75FB0E4-996F-4E52-9464-01DD833CF234Q21133953-A03B8937-0AD5-41BD-AE68-634476BD9798Q21142766-E4FF350F-4E2C-4F26-A765-8254DD6E46BEQ21195671-80112FCC-F549-4236-B635-D0F87534A381Q21245725-179CE102-1125-47E7-9D6B-98C627B6269CQ21261281-A3C96958-9007-4CF9-A7EE-91FA25AEF006Q21284381-C19CF0B6-BB21-46A3-8E39-836C00D76399Q21284385-69978AA2-E6AD-4B3E-A6D0-D236AA611F4FQ21296664-5A352C27-1E35-46D8-A5C0-1FCD06841A65Q23914949-7422AFC8-76E9-48D8-853A-81CAAD409990Q24299850-FD24F819-4D61-4DD1-A660-CFEE10CC981FQ24299896-3551B5EF-7732-438F-A09A-8D03D47033D3Q24300018-FFED0EBB-7D7E-467D-B460-E9A9F6939373Q24301670-6446DBE8-F2C7-42C0-BA21-D15A055FE334Q24301997-F36A5268-D956-4C9B-9CBC-2849FF674451Q24302129-E1527867-37BC-45EC-A362-F59B3CF94060Q24304179-7269027D-5D88-4D3C-B3A9-9334CAC8C590Q24304533-A8D60AEE-1129-4F46-ADC2-69AFF65B92EAQ24306098-55617B87-DE2F-4CD5-95EE-DC6323B308FCQ24306316-34C66B7C-390E-4F95-8677-F082967BAC51Q24307878-C8C87EE1-C94D-4ED0-BA29-DCEC322FBD9AQ24308024-5BD0567D-816D-4A0C-945D-C200B82F0F3CQ24319939-0FEF6964-1258-41BE-944F-C44522595A63Q24321673-3184297E-5D96-4DA2-90A4-24E3B0531E95Q24324150-94377213-EEE1-4258-81C6-AED32D137E14Q24328747-0AE0A237-0222-4A45-926A-0561C1A778E4Q24337932-81368230-FCC0-44D2-8A9D-FD22196B5E66Q24529065-89B269A7-135B-406F-A872-34D9727EEA66Q24536498-D98AF3DD-2663-47F6-A998-12EC00BBBE8EQ24537199-4AFE9FCA-DCAB-45CE-92B2-8A1C537D8994Q24538799-287D89C9-AD94-4D28-9DEE-E7DA89AF1E58Q24597197-B797F0E2-1354-4938-919C-41F6413E990EQ24608005-F2C73BAF-DA2B-423B-86F5-084D2745558AQ24614629-9C3AA182-77E5-401D-BDA2-E9D521C99D79Q24614835-0960B053-6C4B-4EF6-BE0A-8103ADE0C3E3Q24615472-B6C903C5-72AE-413E-8298-93350F8367A3Q24616815-5E602358-2E36-4654-86D3-F8F6CD900AE9
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Targeting HIF-1 for cancer therapy
@ast
Targeting HIF-1 for cancer therapy
@en
Targeting HIF-1 for cancer therapy
@nl
type
label
Targeting HIF-1 for cancer therapy
@ast
Targeting HIF-1 for cancer therapy
@en
Targeting HIF-1 for cancer therapy
@nl
prefLabel
Targeting HIF-1 for cancer therapy
@ast
Targeting HIF-1 for cancer therapy
@en
Targeting HIF-1 for cancer therapy
@nl
P3181
P356
P1476
Targeting HIF-1 for cancer therapy
@en
P2888
P304
P3181
P356
10.1038/NRC1187
P407
P577
2003-10-01T00:00:00Z
P5875
P6179
1034382167